lorglumide has been researched along with Osteogenic Sarcoma in 1 studies
lorglumide: RN given refers to (+-)-isomer
lorglumide : A racemate comprising equal amounts of (R)- and (S)-lorglumide.
N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sturzu, A | 1 |
| Sheikh, S | 1 |
| Klose, U | 1 |
| Echner, H | 1 |
| Kalbacher, H | 1 |
| Deeg, M | 1 |
| Nägele, T | 1 |
| Horger, M | 1 |
| Schwentner, C | 1 |
| Ernemann, U | 1 |
| Heckl, S | 1 |
1 other study available for lorglumide and Osteogenic Sarcoma
| Article | Year |
|---|---|
Potential of the gastric motility drug lorglumide in prostate cancer imaging.
Topics: Cell Line, Tumor; Contrast Media; Flow Cytometry; Fluorescent Dyes; Gastrointestinal Agents; Gastroi | 2012 |